• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA CASC2 通过调控 miR-18a-5p/FBXL3 轴抑制血管内皮细胞瘤细胞的生长。

lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.

机构信息

Department of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

出版信息

J Biol Regul Homeost Agents. 2020 Jan-Feb;34(1):49-56. doi: 10.23812/19-526-A-FULL_ARTICLE.

DOI:10.23812/19-526-A-FULL_ARTICLE
PMID:32138500
Abstract

Dysregulation of lncRNA cancer susceptibility candidate 2 (CASC2) is involved in the pathogenesis of multiple malignancies. However, the underlying mechanisms by which lncRNA CASC2 regulates the proliferation of hemangiomas (HAs) remain undocumented. Herein, the expression levels of lncRNA CASC2 and VEGF in proliferating or involuting phase HAs were assessed by qRT-PCR analysis, and the effects of lncRNA CASC2 on HAs cell growth were evaluated by MTT, colony formation assays and Western blot analysis. lncRNA CASC2 specific binding with miR-18a-5p was confirmed by luciferase report assay. Consequently, we found that the expression of lncRNA CASC2 was reduced in proliferating phase HAs as compared with the involuting phase HAs or normal tissues, and possessed a negative correlation with VEGF expression in proliferating phase HAs. Restored expression of lncRNA CASC2 repressed cell viability and colony formation and downregulated VEGF expression, while silencing lncRNA CASC2 showed the opposite effects. Moreover, lncRNA CASC2 was confirmed to bind with miR-18a-5p, which could reverse lncRNA CASC2-induced anti-proliferative effects by targeting FBXL3 in HAs cells. Altogether, our findings demonstrated that lncRNA CASC2 suppressed the growth of HAs cells by regulating miR-18a-5p/FBXL3 axis.

摘要

长链非编码 RNA 癌症易感性候选物 2(CASC2)的失调参与了多种恶性肿瘤的发病机制。然而,lncRNA CASC2 调节血管瘤(HAs)增殖的潜在机制尚未有文献记载。在此,通过 qRT-PCR 分析评估了增殖期或消退期 HAs 中 lncRNA CASC2 和 VEGF 的表达水平,并通过 MTT、集落形成测定和 Western blot 分析评估了 lncRNA CASC2 对 HAs 细胞生长的影响。通过荧光素酶报告测定证实了 lncRNA CASC2 与 miR-18a-5p 的特异性结合。结果发现,与消退期 HAs 或正常组织相比,增殖期 HAs 中 lncRNA CASC2 的表达降低,并且与增殖期 HAs 中的 VEGF 表达呈负相关。恢复表达 lncRNA CASC2 抑制细胞活力和集落形成,并下调 VEGF 表达,而沉默 lncRNA CASC2 则表现出相反的效果。此外,lncRNA CASC2 被证实与 miR-18a-5p 结合,后者可以通过靶向 FBXL3 逆转 HAs 细胞中 lncRNA CASC2 诱导的抗增殖作用。总之,我们的研究结果表明,lncRNA CASC2 通过调节 miR-18a-5p/FBXL3 轴抑制 HAs 细胞的生长。

相似文献

1
lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.长链非编码 RNA CASC2 通过调控 miR-18a-5p/FBXL3 轴抑制血管内皮细胞瘤细胞的生长。
J Biol Regul Homeost Agents. 2020 Jan-Feb;34(1):49-56. doi: 10.23812/19-526-A-FULL_ARTICLE.
2
Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.上调的长链非编码 RNA CASC2 可能通过调节 miR-18a-5p/RUNX1 抑制恶性黑色素瘤的发展。
Oncol Res. 2019 Feb 21;27(3):371-377. doi: 10.3727/096504018X15178740729367. Epub 2018 Feb 8.
3
Long non-coding RNA cancer susceptibility candidate 2 regulates the function of human fibroblast-like synoviocytes via the microRNA-18a-5p/B-cell translocation gene 3 signaling axis in rheumatoid arthritis.长链非编码 RNA 癌症易感性候选物 2 通过 microRNA-18a-5p/B 细胞易位基因 3 信号轴调节类风湿关节炎中人类成纤维样滑膜细胞的功能。
Bioengineered. 2022 Feb;13(2):3240-3250. doi: 10.1080/21655979.2021.2022075.
4
CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis.CASC2 通过海绵吸附 miR-18a-5p/FIH1 轴抑制甲状腺癌细胞的生长、迁移和侵袭。
Kaohsiung J Med Sci. 2021 Apr;37(4):268-275. doi: 10.1002/kjm2.12331. Epub 2020 Dec 17.
5
Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT and .长链非编码 RNA CASC2 通过靶向 miR-18a 抑制胶质母细胞瘤细胞生长、转移和 EMT。
J Biosci. 2020;45.
6
lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.长链非编码RNA MEG3通过海绵吸附miR-494并调节PTEN/PI3K/AKT通路抑制血管瘤的肿瘤发生。
Cell Physiol Biochem. 2018;51(6):2872-2886. doi: 10.1159/000496040. Epub 2018 Dec 14.
7
Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.长链非编码 RNA CASC2 通过调节 miR-18a-5p/CDK19 促进乳腺癌对紫杉醇的耐药性。
Histochem Cell Biol. 2019 Oct;152(4):281-291. doi: 10.1007/s00418-019-01794-4. Epub 2019 Jul 27.
8
LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease targeting miR-18a-5p/IGF1 axis.长链非编码 RNA CASC2 通过靶向 miR-18a-5p/IGF1 轴参与慢性阻塞性肺疾病的发生。
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211028072. doi: 10.1177/17534666211028072.
9
[The Molecular Mechanism of LncRNA-CASC2/miR-155-5p/APC Axis Regulating the Progression of Non-Hodgkin Lymphoma].[长链非编码RNA-CASC2/miR-155-5p/腺瘤性息肉病基因轴调控非霍奇金淋巴瘤进展的分子机制]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Dec;28(6):1939-1945. doi: 10.19746/j.cnki.issn.1009-2137.2020.06.024.
10
Long non-coding RNA NEAT1 promotes the progression of hemangioma via the miR-361-5p/VEGFA pathway.长链非编码 RNA NEAT1 通过 miR-361-5p/VEGFA 通路促进血管瘤的进展。
Biochem Biophys Res Commun. 2019 May 14;512(4):825-831. doi: 10.1016/j.bbrc.2019.03.084. Epub 2019 Mar 27.

引用本文的文献

1
Long non-coding RNA breast cancer-associated transcript 54 sponges microRNA-1269b to suppress the proliferation of hemangioma-derived endothelial cells.长链非编码 RNA 乳腺癌相关转录本 54 通过海绵吸附 microRNA-1269b 抑制血管内皮细胞瘤的增殖。
Bioengineered. 2022 Mar;13(3):6188-6195. doi: 10.1080/21655979.2022.2027064.
2
miR-18a-5p Targets FBP1 to Promote Proliferation, Migration, and Invasion of Liver Cancer Cells and Inhibit Cell Apoptosis.miR-18a-5p 通过靶向 FBP1 促进肝癌细胞的增殖、迁移和侵袭,抑制细胞凋亡。
Comput Math Methods Med. 2021 Jun 14;2021:3334065. doi: 10.1155/2021/3334065. eCollection 2021.
3
Overexpression of lncRNA CASC2 inhibits the tumorigenesis of thyroid cancer via sponging miR-24-3p.
lncRNA CASC2的过表达通过海绵化miR-24-3p抑制甲状腺癌的肿瘤发生。
Am J Transl Res. 2020 Oct 15;12(10):6314-6324. eCollection 2020.
4
STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.胃癌中的信号转导与转录激活因子3(STAT3)通路:信号传导、治疗靶向及未来展望
Biology (Basel). 2020 Jun 12;9(6):126. doi: 10.3390/biology9060126.